Connect your AI

PTHS PTHS Free cash flow margin

Free cash flow margin at other companies

Cumberland PharmaceuticalsCPIX

3.3%—

Journey Medical CorporationDERM

-43%—

Opko HealthOPK

-30%+0.1pp

Zevra Therapeutics, Inc.ZVRA

-75%-30.5pp

Theravance BiopharmaTBPH

221.9%+206pp

HRO

HarrowHROW

5.7%+5.0pp

Other financials

Income statement

Revenue$10.9M—

Gross profit$9.2M—

Operating income-$13.1M-614%

Net income-$10.2M-420%

EPS (diluted)-$3.09+3.7%

Balance sheet

Cash & equivalents$32.0M+24,250%

Total debt$29.6M—

Total equity$35.1M+937%

Total assets$145.4M+15,855%

Cash flow

Operating cash flow-$13.1M-1,977%

CapEx$194.0K—

Free cash flow-$13.3M-2,008%

Valuation

Market cap$98.22M+92.4%

Enterprise value$95.89M—

P/S3.6×—

Profitability

Gross margin79.6%—

Operating margin-157.7%—

Net margin-186.2%—

Returns & leverage

Return on equity-333.8%—

Debt / equity0.8×—

Current ratio2.8×+2.6×